Decarbonising Pharma webinar: Continuous Flow Synthesis

The pharma industry is one of the largest contributors to greenhouse gas emissions, highlighting an urgent demand for more sustainable practices that produce less waste and prioritise human health and the environment.

Continuous flow synthesis is a chemical manufacturing process in which reactions take place in a continuous stream of fluids, rather than a batch process where reactions occur in a single vessel, typically on a larger scale, with the entire reaction mixture prepared and processed at once. This recently developed method has many advantages over the traditional batch process, such as improved efficiency, safety, and scalability.

We are joined by Dr Amol Kulkarni, Research Scientist at National Chemical Laboratory (NCL) in Pune, India, who will be discussing how sustainable practices can be integrated into the chemical industry, with a focus on continuous processes that do not heavily rely on solvents. Check out the webinar below to find out how NCL is collaborating with CPI to implement greener, more continuous practices that make a significant step towards reducing the industry's carbon footprint.

This webinar will explore:

  • What are Scope 1, 2 and 3 emissions?
  • Industry macroeconomic trends and drivers
  • Goals and targets of the pharma industry
  • Advantages and application of continuous flow synthesis
  • How can we implement greener, more sustainable practices?

Fill in the form to watch the webinar

CPI is your innovation partner to make your ideas a reality.